Comparative Experimental Study Between Bupivacaine and Ropivacaine Regarding Efficacy in Third Molar Removal Surgery Under General Anesthesia
Henrique Tedesco
15 participants
Jul 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare the efficacy of bupivacaine and ropivacaine in third molar removal surgery under general anesthesia in healthy volunteers. The main question aims to determine whether there is any difference in vital signs, hemostasis and postoperative pain between ropivacaine and bupivacaine in patients undergoing third molars extraction under general anesthesia. Researchers will compare bupivacaine and ropivacaine in a split-mouth study to determine if one drug is more effective in third molar extraction surgery under general anesthesia (better hemostasis, less postoperative pain, and fewer changes in vital signs). Participants will undergo a single surgical procedure and complete the Visual Analog Scale to record postoperative pain
Eligibility
Inclusion Criteria3
- Patients aged 18 to 60
- Patients ASA Physical Status Classification I and II
- Patients with impacted or semi-impacted lower third molars with similar positioning on both sides according to the Pell and Gregory classification
Exclusion Criteria2
- Patients who can have surgery under local anesthesia
- Patients where more procedures are required in the same surgical session
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Injection of bupivacaine 0,5% in group A
Injection of ropivacaine 0,75% in group B
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07108465